Evidence map›Paper›PMID 31465494›Full record

ArticlePloS one2019

Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP).

Tafireyi Marukutira, Lisa Block, Mary Grace Alwano, Stephanie Behel, Joseph N Jarvis, Unoda Chakalisa, Kate Powis, Vladimir Novitsky, William Bapati, Huisheng Wang and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01965470 (Botswana Combination Prevention Project), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01965470 phase4completednot on this map

Botswana Combination Prevention Project: -Evaluation Protocol (Protocol #1): Research Design and Impact Evaluation -Closed Clinical Cohort Protocol (Protocol #3) Implementation, Monitoring and Evaluation of Combination HIV Prevention Interventions in Rural and Peri-Urban Communities in Botswana

TypeinterventionalSponsorCenters for Disease Control and PreventionRan2013 to 2018ConditionsHIVArmsCombination Prevention, Enhanced Care
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Observational
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 4 countries.

Tafireyi MarukutiraCenters for Disease Control and Prevention, Gaborone, Botswana.ORCID 0000-0003-1142-6114
Lisa BlockNorthrop Grumman Corporation, Atlanta, Georgia, United States of America.
Mary Grace AlwanoCenters for Disease Control and Prevention, Gaborone, Botswana.
Stephanie BehelDivision of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Joseph N JarvisCenters for Disease Control and Prevention, Gaborone, Botswana.
Unoda ChakalisaBotswana-Harvard Partnership, Gaborone, Botswana.
Kate PowisBotswana-Harvard Partnership, Gaborone, Botswana.
Vladimir NovitskyHarvard T.H Chan School of Public Health, Boston, Massachusetts, United States of America.
William BapatiTebelopele HIV Testing and Counselling Centre, Gaborone, Botswana.
Huisheng WangNorthrop Grumman Corporation, Atlanta, Georgia, United States of America.
Faith UsseryDivision of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Refeletswe LebelonyaneDepartment of HIV/AIDS Prevention and Care, Botswana Ministry of Health, Gaborone, Botswana.
Lisa A MillsCenters for Disease Control and Prevention, Gaborone, Botswana.
Janet MooreDivision of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Pamela BachanasDivision of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Centers for Disease Control and Prevention · USHarvard University · USNorthrop Grumman (United States) · USBotswana Harvard AIDS Institute Partnership · BWBurnet Institute · AULondon School of Hygiene & Tropical Medicine · GBMinistry of Health · BW

Funding

CGH CDC HHS U01 GH000447CGH CDC HHS U2G GH000073CGH CDC HHS U2G GH000419CGH CDC HHS U2G GH001911
6 · The paper itself

Abstract

introductionNon-citizens often face barriers to HIV care and treatment. Quantifying knowledge of positive HIV status and antiretroviral therapy (ART) coverage among non-citizens in a high HIV-prevalence country like Botswana that is close to achieving UNAIDS "90-90-90" targets may expose important gaps in achieving universal HIV testing and treatment.

methodsThe Botswana Combination Prevention Project (BCPP) is a pair-matched cluster-randomized trial evaluating the impact of prevention interventions on HIV incidence in 30 rural or peri-urban communities. Community case finding and HIV testing were conducted in home and mobile venues in 15 intervention communities from October 2013-September 2017. In this secondary analysis, we compared HIV positivity, knowledge of positive HIV-status, and ART status among all citizens and non-citizens assessed at intake in the intervention communities.

resultsHIV status was assessed in 57,556 residents in the intervention communities; 4% (n = 2,463) were non-citizens. Five communities accounted for 81% of the total non-citizens assessed. A lower proportion of non-citizens were HIV-positive (15%; n = 369) compared to citizens (21%; n = 11,416) [p = 0.026]; however, a larger proportion of non-citizens did not know their HIV-positive status prior to BCPP testing (75%) as compared to citizens (15%) [p = 0.003]. Among residents with knowledge of their HIV-positive status before BCPP, 79% of the non-citizens (72/91) were on ART compared to 86% (8,267/9,652) of citizens (p = 0.137).

conclusionsAlthough non-citizens were less likely to know their HIV-positive status compared to citizens, there were no differences in treatment uptake among non-citizens and citizens who knew their status. Designing interventions for non-citizens that provide HIV testing and treatment services commensurate to that of citizens as well as targeting communities with the largest number of non-citizens may help close a meaningful gap in the HIV care cascade and ensure ethical treatment for all HIV-positive persons.

trial registrationClinicalTrials.gov: NCT01965470 (Botswana Combination Prevention Project).

Indexed as

Healthcare DisparitiesHealth Knowledge, Attitudes, PracticeResidence CharacteristicsAdolescentAdultAntiretroviral Therapy, Highly ActiveBotswanaFemaleHIV InfectionsHumansMaleMiddle AgedOutcome Assessment, Health CarePublic Health SurveillanceYoung Adult

Identifiers

PMID31465494
PMCPMC6715216
OpenAlexW2970192026

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.